The value of lateral lymphoscintigraphy images of the pelvis for gynecological cancers: Are they necessary?

Document Type: Original Article

Authors

1 Women's Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2 Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

3 Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Introduction: In the current study we evaluated the incremental value of lateral pelvic lymphoscintigraphy imaging of endometrial or cervical cancer patients who underwent sentinel node mapping.
Methods: Operable endometrial and cervical cancer patients without clinical or paraclinical evidence of lymph node involvement were included in the study. The day before surgery the patients were sent to the nuclear medicine department for injection of the radiotracer. All patients received two intra-cervical injection of 1 mCi/0.2 cc radiotracer in the 6 and 12 hour locations. 18-24 hours after the radiotracer, lymphoscintigraphy imaging in anterior/posterior and lateral views was done. After induction of anesthesia, 2 mL Methylene blue in two aliquots was injected intra-cervically in the same location as the radiotracers. During operation, any hot and/or blue node was harvested as sentinel nodes.
Results: Overall 40 patients were included in the study (30 endometrial and 10 cervical cancers). Sentinel node visualization was achieved in 30 patients. These sentinel nodes were all visualized on the ANT/POST views. Only in 7 patients sentinel nodes could be visualized on the lateral views. Intra-operative sentinel node detection rate was 38 out of 40 (95%). Radiotracer detection rate was 37/40 (92.5%) and blue dye detection rate was 17/40 (42.5%).

Conclusion: Anterior/Posterior pelvic lymphoscintigraphy imaging is sufficient for imaging in cervical and endometrial cancer patients undergoing sentinel node mapping. Lateral views can be omitted due to limited valued of these projections.

Keywords

Main Subjects


Suh DH, Kim K, Kim JW. Major clinical research advances in gynecologic cancer in 2011. J Gynecol Oncol. 2012 Jan;23(1):53-64.

Marnitz S, Köhler C. Current therapy of patients with endometrial carcinoma. A critical review. Strahlenther Onkol. 2012 Jan;188(1):12-20.

Hertel H. Cervical cancer and the role of lymph node staging cons sentinel concept. Int J Gynecol Cancer. 2010 Oct;20(11 Suppl 2):S37-8.

Chéreau E, Feron JG, Ballester M, Coutant C, Bezu C, Rouzier R, Touboul E, Daraï E. Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2-IIB cervical cancer. Br J Cancer. 2012 Jan 3;106(1):39-44.

Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C, Chi DS, Barakat RR. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol. 2006 Nov;103(2):714-8.

Van Oostrum NH, Makar AP, Van Den Broecke R. Sentinel node procedures in gynecologic cancers: an overview. Acta Obstet Gynecol Scand. 2012 Feb;91(2):174-81.

Sadeghi R, Forghani MN, Zakavi SR, Jangjoo A, Shabani GA, Dabbagh Kakhki VR. The need for skin pen marking for sentinel lymph node biopsy: A comparative study. Iran J Nucl Med. 2008;16(2):23-7.

Miwa K, Nishimura G, Tsugawa K, Kinami S. Review of sentinel lymph node research from the viewpoint of clinical significance. Gan To Kagaku Ryoho. 2004 Mar;31(3):457-60.

Sadeghi R, Forghani MN, Memar B, Abdollahi A, Zakavi SR, Mashhadi MT, Raziee HR, Tavassoli A, Kakhki VR. Comparison of pre-operative lymphoscintigraphy with inter-operative gamma probe and dye technique regarding the number of detected sentinel lymph nodes. Hell J Nucl Med. 2009 Jan-Apr;12(1):30-2.

Momennezhad M, Zakavi SR, Dabbagh Kakhki VR, Jangjoo A, Ghavamnasiri MR, Sadeghi R. Scatterogram: a method for outlining the body during lymphoscintigraphy without using external flood source. Radiol Oncol. 2011 Sep;45(3):184-8.

Sadri K, Ayati NK, Shabani G, Zakavi SR, Sadeghi R. Sentinel node detection failure due to defective labeling and large particle size of Tc-99m antimony sulfide colloid. Iran J Nucl Med. 2011;19(1):6-11.

Dabbagh Kakhki VR, Jangjoo A, Tavassoli A, Asadi M, Sadri K, Fatahi Masoom A, Mehrabibahar M, Memar B, Ansari M, Sadeghi R. Sentinel node mapping for early breast cancer patients using 99mTc-phytate: Single center experience on 165 patients. Iran J Nucl Med. 2012;20(2):25-9.

Vidal-Sicart S, Doménech B, Luján B, Pahisa J, Torné A, Martínez-Román S, Antonio Lejárcegui J, Fusté P, Ordi J, Paredes P, Pons F. Sentinel node in gynaecological cancers. Our experience. Rev Esp Med Nucl. 2009 Sep-Oct;28(5):221-8.

Jangjoo A, Forghani MN, Mehrabibahar M, Sadeghi R. Anaphylaxis reaction of a breast cancer patient to methylene blue during breast surgery with sentinel node mapping. Acta Oncol. 2010 Aug;49(6):877-8.

Díaz-Feijoo B, Pérez-Benavente MA, Cabrera-Diaz S, Gil-Moreno A, Roca I, Franco-Camps S, Fernández MS, García-Jiménez A, Xercavins J, Martínez-Palones JM. Change in clinical management of sentinel lymph node location in early stage cervical cancer: the role of SPECT/CT. Gynecol Oncol. 2011 Mar;120(3):353-7.

Momennezhad M, Haghighi Kakhki HR, Sadeghi R. Body outlining using Tc-99m filled flood source for lymphoscintigraphy imaging. Iran J Nucl Med. 2011;19 (1):59-63.

Johnson CB, Boneti C, Korourian S, Adkins L, Klimberg VS. Intraoperative injection of subareolar or dermal radioisotope results in predictable identification of sentinel lymph nodes in breast cancer. Ann Surg. 2011 Oct;254(4):612-8.

Jangjoo A, Forghani MN, Mehrabibahar M, Rezapanah A, Kakhki VR, Zakavi SR, Ghavamnasiri MR, Kashani I, Hashemian F, Sadeghi R. Comparison of early and delayed lymphoscintigraphy images of early breast cancer patients undergoing sentinel node mapping. Nucl Med Commun. 2010 Jun;31(6):521-5.

Sadeghi R. Sentinel node biopsy in medical practice: more than 6 years of practice in Mashhad. Iran J Nucl Med. 2010;18(suppl 1):56.

Amoui M, Akbari ME, Tajeddini A, Nafisi N, Raziei G, Modares SM, Hashemi M. Value of sentinel lymph node biopsy in breast cancer surgery with simple pathology facilities--an Iranian local experience with a review of potential causes of false negative results. Asian Pac J Cancer Prev. 2012;13(11):5385-9.

Eftekhari M, Beiki D, Fallahi B, Arabi M, Memari F, Gholamrezanezhad A, Esmaili J, Akhzari F, Fard-Esfahani A. Assessment the diagnostic accuracy of sentinel lymph nodes lymphoscintigraphy using Technetium-99m phytate in breast cancer. Daru 2009;17(2):83-7.

Barlin JN, Khoury-Collado F, Kim CH, Leitao MM Jr, Chi DS, Sonoda Y, Alektiar K, DeLair DF, Barakat RR, Abu-Rustum NR. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol. 2012 Jun;125(3):531-5.

Yamashita T, Katayama H, Kato Y, Nishiwaki K, Hayashi H, Miyokawa N, Sengoku K. Management of pelvic lymph nodes by sentinel node navigation surgery in the treatment of invasive cervical cancer. Int J Gynecol Cancer. 2009 Aug;19(6):1113-8.

Vidal F, Leguevaque P, Motton S, Delotte J, Ferron G, Querleu D, Rafii A. Evaluation of the sentinel lymph node algorithm with blue dye labeling for early-stage endometrial cancer in a multicentric setting. Int J Gynecol Cancer. 2013 Sep;23(7):1237-43.

Belhocine TZ, Prefontaine M, Lanvin D, Bertrand M, Rachinsky I, Ettler H, Zabel P, Stitt LW, Sugimoto A, Urbain JL. Added-value of SPECT/CT to lymphatic mapping and sentinel lymphadenectomy in gynaecological cancers. Am J Nucl Med Mol Imaging. 2013;3(2):182-93.

Kraft O, Havel M. Sentinel lymph nodes and planar scintigraphy and SPECT/CT in various types of tumours. Estimation of some factors influencing detection success. Nucl Med Rev Cent East Eur. 2013;16(1):17-25.